Appointment News
Pfizer appoints new head of oncology R&D
Pfizer has appointed Jeff Settleman to lead its oncology research and development, from discovery to proof of concept clinical studies.
As Senior Vice President and...
Gilead poaches BMS president for new CCO
Johanna Mercier has been named as Chief Commercial Officer of California’s Gilead Sciences, replacing Laura Hamill.
Ms Hamill, Executive Vice President Worldwide Commercial Operations, will...
CANbridge Pharmaceuticals strengthens senior team
CANbridge Pharmaceuticals has appointed Glenn Hassan as Chief Financial Officer and Chief Business Officer, and Dr Gerald F. Cox in an advisory capacity as...
Kymab appoint industry veteran as new CEO
Kymab, a UK biopharma developing antibody-based therapeutics, has appointed Simon Sturge as its new CEO.
He succeeds David Chiswell, who remains a scientific adviser to...
UK DDR specialist appoints Chief Medical Officer
Artios Pharma, a UK-based DNA Damage Response (DDR) company, has appointed Ian Smith as its Chief Medical Officer.
Mr Smith joins from Eli Lilly where,...
